Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo.
Matthews DJ, Yakes FM, Chen J, Tadano M, Bornheim L, Clary DO, Tai A, Wagner JM, Miller N, Kim YD, Robertson S, Murray L, Karnitz LM.
Matthews DJ, et al. Among authors: bornheim l.
Cell Cycle. 2007 Jan 1;6(1):104-10. doi: 10.4161/cc.6.1.3699. Epub 2007 Jan 7.
Cell Cycle. 2007.
PMID: 17245119